Most Recent

image: Opinion: Understanding and Coping With Rising Publication Costs

Opinion: Understanding and Coping With Rising Publication Costs

By M. Bishr Omary and Theodore S. Lawrence | September 1, 2017

As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.


image: Opinion: Why I Published in a Predatory Journal

Opinion: Why I Published in a Predatory Journal

By John H. McCool | April 6, 2017

Our totally bogus case report swiftly passed muster, with only minor revisions requested.


Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.


image: Pet Scans

Pet Scans

By Timothy M. Fan, Amy K. LeBlanc, and Nicola Mason | April 1, 2016

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.


image: Body, Heal Thyself

Body, Heal Thyself

By Jason Liebowitz | September 1, 2015

Reviving a decades-old hypothesis of autoimmunity


image: Hurdles for Hearing Restoration

Hurdles for Hearing Restoration

By Bernd Fritzsch | September 1, 2015

Given the diverse cell types and complex structure of the human inner ear, will researchers ever be able to re-create it?

1 Comment

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Facing Down Emerging Viruses

Facing Down Emerging Viruses

By Michal Barski | February 1, 2015

A better knowledge of the pathogenesis of emerging zoonotic diseases is crucial if we want to prepare for “the next Ebola.”


image: A Matter of Size

A Matter of Size

By Scott McNeil | August 1, 2014

Erroneous characterization of nanomaterials can misinform the study of a new medicine’s safety and efficacy.


Popular Now

  1. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  2. University of Oregon Erecting a $1-Billion Science Center
  3. Investigation Finds Signs of Misconduct in Swedish Researcher’s Papers
  4. Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test